Weekly Inflows: Grand Bank Yachts, Huationg Global, BTOU & 1J5 See Huge Acquisitions
The four trading sessions had close to 90 changes to director interests and substantial shareholdings filed for nearly 50 primary-listed stocks.
Directors or chief executive officers filed 19 acquisitions and four disposals, while substantial shareholders filed six acquisitions and four disposals.
1.Grand Bank Yachts
Willimbury, a private company incorporated in Australia, increased its substantial shareholding in $Grand Banks(G50.SI)$ above the 15% threshold on Mar 28.
The married deal involved 1,709,500 shares being acquired at S$0.31 apiece, boosting the company’s direct interest to 15.79% from 14.86%. It had raised its direct interest above the 14% threshold in June 2022, with that acquisition also transacted at an average price of S$0.31 per share.
2.Huationg Global
On Apr 1, $Huationg Global(41B.SI)$ CEO and executive director Patrick Ng Kian Ann acquired 12.5 million shares in a married deal at S$0.142 per share. With a consideration of nearly S$1.8 million, this increased his direct interest in the civil engineering services provider to 7.75%, from 0.69%.
Mehta Vimesh Piyush was on the other side of the married deal, with his direct interest in the Catalist-listed company reduced to 0.96% from 8.1%. His previous acquisition was on Aug 31, 2023, with 200,000 shares acquired at an average price of S$0.131 apiece.
Ng also maintained a 68.7% deemed interest in Huationg Global by virtue of his 25% shareholding interest in Dandelion Capital, which is the immediate and ultimate holding company of Huationg. The acquisition brings his total interest in the Catalist-listed company to 76.45%.
3.Manulife US Reit
On Apr 4, Manulife US Real Estate Management independent non-executive director Francis Koh Cher Chiew acquired 400,000 units of $ManulifeReit USD(BTOU.SI)$ at US$0.0755 per unit.
This increased his direct interest in the Reit to 450,000 units, or 0.025%.
4.Hyphens Pharma International
On Apr 1, $Hyphens Pharma(1J5.SI)$ non-executive director Tan Kia King acquired 32,000 shares at S$0.275 per share.This increased his total interest in the Catalist-listed company marginally to 28.02% from 28.01%.
Dr Tan has more than 25 years of experience as a medical doctor, starting his career as a medical officer in the Ministry of Health. He was also the managing director of Westpoint Family Hospital, where he was responsible for overseeing the day-to-day operations.
https://www.sgx.com/research-education/market-updates/20240408-huationg-global-ceo-increases-interest-775
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
